Individualizing nutrition in patients with acute respiratory failure requiring mechanical ventilationMLYNAREK, M; ZAROWITZ, B. J.Drug intelligence & clinical pharmacy. 1987, Vol 21, Num 11, pp 865-870, issn 0012-6578Article

Optimal heart rate control for patients with chronic atrial fibrillation : are pharmacologic choices truly changing ?ZAROWITZ, B. J; MIHAI GHEORGHIADE.The American heart journal. 1992, Vol 123, Num 5, pp 1401-1403, issn 0002-8703Article

Bioelectrical impedance in clinical practiceZAROWITZ, B. J; PILLA, A. M.DICP (Cincinnati, Ohio). 1989, Vol 23, Num 7-8, pp 548-555, issn 1042-9611Article

Reinstitution of digoxin after digoxin Fab antibody therapy in a hemodialyzed patientROBERT, S; UJHELYI, M. R; ZAROWITZ, B. J et al.Critical care medicine. 1993, Vol 21, Num 10, pp 1585-1587, issn 0090-3493Article

Changing perspectives of stress gastritis prophylaxisSMYTHE, M. A; ZAROWITZ, B. J.The Annals of pharmacotherapy. 1994, Vol 28, Num 9, pp 1073-1085, issn 1060-0280Article

Characterization of drug disposition and dosing using bioelectrical impedanceZAROWITZ, B. J; PETERSON, E. L; ROBERT, S et al.Medical progress through technology. 1993, Vol 19, Num 4, pp 193-198, issn 0047-6552Conference Paper

Is it time to reposition vasopressors and inotropes in sepsis ?RUDIS, M. I; BASHA, M. A; ZAROWITZ, B. J et al.Critical care medicine. 1996, Vol 24, Num 3, pp 525-537, issn 0090-3493Article

Expanded gentamicin volume of distribution in patients with indicators of malnutritionZAROWITZ, B. J; PILLA, A. M; POPOVICH, J. JR et al.Clinical pharmacy. 1990, Vol 9, Num 1, pp 40-44, issn 0278-2677Article

Predictability of creatinine clearance estimates in critically ill patientsROBERT, S; ZAROWITZ, B. J; PETERSON, E. L et al.Critical care medicine. 1993, Vol 21, Num 10, pp 1487-1495, issn 0090-3493Article

A primer on continuous renal replacement therapy for critically III patientsJOY, M. S; MATZKE, G. R; ARMSTRONG, D. K et al.The Annals of pharmacotherapy. 1998, Vol 32, Num 3, pp 362-375, issn 1060-0280Article

Technical and interpretive problems of peripheral nerve stimulation in monitoring neuromuscular blockade in the intensive care unitRUDIS, M. I; GUSLITS, B. G; ZAROWITZ, B. J et al.The Annals of pharmacotherapy. 1996, Vol 30, Num 2, pp 165-172, issn 1060-0280Article

Bar code documentation of pharmacotherapy services in intensive care unitsZAROWITZ, B. J; PETITTA, A; RUDIS, M. I et al.Pharmacotherapy. 1996, Vol 16, Num 2, pp 261-266, issn 0277-0008Article

Estimation of total body and extracellular water using single- and multiple-frequency bioimpedancePATEL, R. V; MATTHIE, J. R; WITHERS, P. O et al.The Annals of pharmacotherapy. 1994, Vol 28, Num 5, pp 565-569, issn 1060-0280Article

Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unitRUDIS, M. I; GUSLITS, B. J; PETERSON, E. L et al.Critical care medicine. 1996, Vol 24, Num 10, pp 1749-1756, issn 0090-3493Article

Electrophysiologic and proarrhythmic effects of intravenous inotropic agentsTISDALE, J. E; RAKESH PATEL; WEBB, C. R et al.Progress in cardiovascular diseases. 1995, Vol 38, Num 2, pp 167-180, issn 0033-0620Article

Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humansTISDALE, J. E; RUDIS, M. I; PADHI, I. D et al.Journal of clinical pharmacology. 1995, Vol 35, Num 9, pp 902-910, issn 0091-2700Conference Paper

Determination of gentamicin pharmacokinetics by bioelectrical impedance in critically ill adultsZAROWITZ, B. J; ROBERT, S; MLYNAREK, M et al.Journal of clinical pharmacology. 1993, Vol 33, Num 6, pp 562-567, issn 0091-2700Article

Disposition of digoxin immune Fab in patients with kidney failureUJHELYI, M. R; ROBERT, S; CUMMINGS, D. M et al.Clinical pharmacology and therapeutics. 1993, Vol 54, Num 4, pp 388-394, issn 0009-9236Conference Paper

Review of randomized trials of digoxin therapy in patients with chronic heart failure. DiscussionGHEORGHIADE, M; ZAROWITZ, B. J; LEWIS et al.The American journal of cardiology. 1992, Vol 69, Num 18, pp 48G-63G, issn 0002-9149Conference Paper

A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patientsRUDIS, M. I; SIKORA, C. A; ANGUS, E et al.Critical care medicine. 1997, Vol 25, Num 4, pp 575-583, issn 0090-3493Article

Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patientsZAROWITZ, B. J; RUDIS, M. I; LAI, K et al.Pharmacotherapy. 1997, Vol 17, Num 2, pp 327-332, issn 0277-0008Article

Bioelectrical impedance analysis measurements for drug pharmacokineticsZAROWITZ, B. J.The American journal of clinical nutrition. 1996, Vol 64, Num 3, pp 519S-523S, issn 0002-9165, SUPConference Paper

Labetalol : response and safety in critically ill hemorrhagic stroke patientsPATEL, R. V; KERTLAND, H. R; JAHNS, B. F et al.The Annals of pharmacotherapy. 1993, Vol 27, Num 2, pp 180-181, issn 1060-0280Article

Population pharmacokinetics of gentamicin: use of the nonparametric expectation maximisation (NPEM) algorithmKISOR, D. F; WATLING, S. M; ZAROWITZ, B. J et al.Clinical pharmacokinetics. 1992, Vol 23, Num 1, pp 62-68, issn 0312-5963Article

Body composition analysis by bioelectrical impedance : the effects of time of day and body side on estimated gentamicin pharmacokineticsROBERT, S; ZAROWITZ, B. J; PILLA, A. M et al.Pharmacotherapy. 1991, Vol 11, Num 2, pp 122-126, issn 0277-0008, 5 p.Article